Dramatic Response of a Metastatic Primary Small-Cell Carcinoma of the Pancreas to a Trial of Immunotherapy with Nivolumab: A Case Report
Extrapulmonary small-cell neuroendocrine cancers are rare in clinical practice. They are frequently metastatic at the time of diagnosis with survival in months even with the most intensive treatment. So far, treatment recommendations for this group rely on data from the similar but more common small...
Main Authors: | Justin Kenneth Ugwu, Chiemeziem Nwanyanwu, Abhay Ramchandra Shelke |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2017-08-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/479315 |
Similar Items
-
Bilateral uveitis associated with nivolumab therapy for metastatic non-small cell lung cancer
by: Christopher R. Dermarkarian, MD, et al.
Published: (2020-06-01) -
Five-year results of nivolumab for the treatment of non-small cell lung cancer in clinical practice of the N.N. Blokhin Russian Cancer Research Center
by: D. I. Yudin, et al.
Published: (2021-08-01) -
Three-year results of application of nivolumab in patients with non-small cell lung cancer in clinical practice of the N.N. Blokhin Russian Cancer Research Center
by: K. K. Laktionov, et al.
Published: (2019-12-01) -
Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer
by: Abdoulaye Karaboué, et al.
Published: (2022-02-01) -
Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature
by: Shagufta Shaheen, et al.
Published: (2018-05-01)